KEGG pathway analysis revealed that the “p53 signaling pathway” was upregulated by PFD or NTD treatment (Table 5 and Table 7); however, it was not present in the DEGs between patients with IPF and HCs. This evidence concerns the gene TP53 and polyostotic fibrous dysplasia.